Category: oncology retractions

In detailed notice, radiology journal retracts lung cancer paper for likely plagiarism

The editors of Acta Radiologica have retracted a study of patients with lung cancer, with a notice that tells the whole story:

The manuscript “Measurement of tumor volume by PET to evaluate prognosis in patients with advanced non-small cell lung cancer treated by non-surgical therapy” was submitted to Acta Radiologica on November 3, 2010 and, after a review, accepted for publication on February 26, 2011 (1). The article was published in Acta Radiol 2011;52:646–50. Authors were: Honjiang Yan, Renben Wang (corresponding author), Fen Zhao, Kubli Zhu, Shumei Jiang, Wei Zhao, and Rui Feng, from the Department of Radiation Oncology and Department of Nuclear Medicine, Shandong Tumor Hospital, Jinan, China. Continue reading In detailed notice, radiology journal retracts lung cancer paper for likely plagiarism

Correction for MD Anderson’s Bharat Aggarwal arches eyebrows for the right reasons

We’ve written about mega-corrections that allow scientists to retrace virtually all of their steps yet preserve their publications as supposedly legitimate. And we’ve seen plenty of corrections that allow authors to assert that their conclusions are correct when evidently important pieces of data are themselves unreliable.

Now comes a correction that seems to us to strike the right chords, given the fact that editors are to a large extent at the mercy of authors in these situations. Continue reading Correction for MD Anderson’s Bharat Aggarwal arches eyebrows for the right reasons

Another retraction for Anil Potti, with an inscrutable notice

We’ve seen a lot of retraction notices for work by Anil Potti — 10, to be precise, along with 7 corrections and one partial retraction notice. As notices go, they tend to be pretty complete. So when we saw one in CHEST for this 2008 abstract, we were expecting something similar.

Instead, we were confused.

Here’s the notice: Continue reading Another retraction for Anil Potti, with an inscrutable notice

Three gynecologic cancer studies retracted for figure duplication, image manipulation

A gynecologic cancer researcher at Oita University in Japan has retracted three papers by his group after the discovery of duplicated figures and manipulated images.

The three papers by Noriyuki Takai and colleagues all appeared in Gynecologic Oncology: Continue reading Three gynecologic cancer studies retracted for figure duplication, image manipulation

Authors retract “one-center” cancer study for plagiarizing from…another center

The World Journal of Surgical Oncology has posted the retraction of a 2010 article by Italian researchers who lifted substantial parts of their text from a group that had published on the same topic seven years earlier.

The article, “Colon and rectal surgery for cancer without mechanical bowel preparation: one-center randomized prospective trial,” came from a group of surgical oncologists at San Martino Hospital in Genoa led by Stefano Scabini, who is listed in other publications as chief of the service.

According to the notice: Continue reading Authors retract “one-center” cancer study for plagiarizing from…another center

Retraction for prostate cancer paper duplication leaves authors penitent, “happy”

Perhaps fittingly in today’s age of sensitive feelings, the typical reaction to a retraction (per the notices, at least) is apology. But bliss?

Expert Opinion on Investigational Drugs has a new one in the annals of penitence. At issue is a 2010 paper titled “Horizon scanning for novel therapeutics for the treatment of prostate cancer,” by Dieletta Bianchini. Turns out the authors had published the same (or nearly so) paper two months earlier in a different journal. Here’s the notice: Continue reading Retraction for prostate cancer paper duplication leaves authors penitent, “happy”

Another XMRV shoe drops: PLoS Pathogens study linking prostate cancer to virus retracted

Less than 24 hours after the publication of a study showing no link between XMRV, aka xenotropic murine leukemia-related virus, and chronic fatigue syndrome (CFS), the authors of a a study claiming a link between the virus and prostate cancer have has been retractedit. The move comes along with the publication of a new study showing that no such link exists.

Here’s the notice, from PLoS Pathogens: Continue reading Another XMRV shoe drops: PLoS Pathogens study linking prostate cancer to virus retracted

Two more retractions for Spanish leukemia researcher Román-Gómez

The journal Haematologica has retracted two papers by José Román-Gómez, both of which involve image manipulation, bringing his total to four.

Here’s the first notice, for a 2007 article titled “Epigenetic regulation of human cancer/testis antigen gene, HAGE, in chronic myeloid leukemia” that has been cited 20 times, according to Thomson Scientific’s Web of Knowledge: Continue reading Two more retractions for Spanish leukemia researcher Román-Gómez

Glasgow’s Beatson Institute investigating circumstances of Cell retraction for inappropriate images

The Beatson Institute for Cancer Research in Glasgow, Scotland is looking into how inappropriate images ended up in a Cell paper that has just been retracted.

Here’s the notice for the paper by Lynne Marshall, Niall S. Kenneth, and Robert J. White: Continue reading Glasgow’s Beatson Institute investigating circumstances of Cell retraction for inappropriate images

Authors, including highly cited cancer researcher, blame “clerical error” for image mixup in paper

The Journal of Experimental Medicine has issued a correction for a 2011 paper by Michael Karin, a prominent cancer researcher at the University of California, San Diego, after learning about a “clerical error” in one of the figures.

According to the notice for the article, “Constitutive intestinal NF-κB does not trigger destructive inflammation unless accompanied by MAPK activation,” Continue reading Authors, including highly cited cancer researcher, blame “clerical error” for image mixup in paper